SlideShare a Scribd company logo
Acute Kidney Injury
Dr Thuzar Win
Lecturer
Department of Medicine
University of Medicine (2) Yangon
Definition
Refers to a sudden and usually reversible
loss of renal function, which develops
over a period of days or weeks.
Working Definition
 Serum creatinine rises by 26 µmol/L within 48 hours;
or
 Serum creatinine rises by 1.5-fold from the baseline
value, either known or thought to have occurred
within one week; or
 Urine output is less than 0.5 mL/kg/hour for more
than six consecutive hours.
Causes
Are divided into
I. Pre-renal (usually reversible and
commonest) -55-60%
II. Intrinsic renal -35-40%
III. Post-renal - < 5 %
I. Pre-renal causes
(a) systemic
i – Intravascular volume deplesion
 haemorrhage,
 GI loss,
 renal loss by excessive diuresis,
 increased insensible loss
 third space losses (pancretitis, crush
Syndrome)
continuation from pre-renal
cause-1
• ii - Decreased cardiac output
a) cardiac failure,
b) systemic vasodilatation
c) drug induced
d) sepsis, liver failure, anaphylaxis
continuation from pre-renal
cause-2
(b) local
i - renal artery occlusion or stenosis
ii - disease affecting renal arterioles
iii - renal vasoconstrition(norepinephrine,
ergotamine,liver disease, sepsis, hypercalcemia).
iv - pharmacological agents that acutely
impair the autoregulation and GFR( ACEI, NSAIDs )
II. Intrinsic renal disease
(a) Acute tubular necrosis 85%
Toxic / Septic renal failure
(b) Glomerular disease
- Primary
- Component of systemic disease 5%
(vasculitis, accelerated hypertension, DIC)
(c) Interstitial disease 10%
(acute allergic interstitial nephritis due to drugs)
III. Post-renal
(a) Stones
(b) Inflammation if it is bilateral
(c) Tumor.
Pathogenesis
I. Pre-renal
Kidney can regulate its own blood flow and GFR over a wide range of
perfusion pressures
Compensatory mechanism
(a) VD of afferent arterioles (b) VC of efferent arterioles
- mechanical
- neurohumoral
-PGs which is
inhibited by
NSAIDs.
-Renin
-Ag II which is
inhibited by
ACEI
When compensatory mechanism fails, intact renal
tubules become hyperfunctional and lead to increase
absorption of Na and H2O.
Physical factors
Angiotensin, Aldosterone,
Vasopressin
low urine volume.(Hyperosmolar)
low urinary Na.
II. Intrinsic renal
(a) Acute tubular necrosis (ATN)
(b) Sepsis
(c) Rapidly progressive glomerulonephritis (RPGN)
(a) Acute Tubular Necrosis (ATN)
(i) ischaemic ATN
(ii) nephrotoxic ATN
(a) (i) ischaemic ATN
- follows after shock and renal blood flow remains 20% of normal
- reduced O2 delivery to tubular cells.
- peroxidation of cell membrane lipids, influx of Ca and cell swelling.
- mitochondrial function impaired
- anaerobic glycolysis and intracellular acidosis
- lysosomal disruption, denaturing of protein and DNA
tubular cell death
(a) (ii) Nephrotoxic ATN
- Direct toxicity to tubular cells
- Production of reactive O2 species and peroxidation of membrane
lipids
- interfere with cellular respiration and inhibition of cell protein
synthesis
tubular cell death
Tubular cell death
- loss of adhesion between tubular cell and basement membrane
- shedding of cell -focal break in tubular
into tubular lumen basement membrane
tubular obstruction - tubular content leak into
interstitial tissue
interstitial oedema
(b) Sepsis (many mechanisms causing ATN)
- Generated arterial vasodilatation.
- Activation of sympathetic nervous system.
- Activation of RAA axis (vascular resistance)
- Non-osmotic release of vasopressin.
- Increase in cardiac output.
- Development of DIC.
- Deficiency of stress hormones, cortisol.
- Metabolic changes like hyperglycemia.
- Fortunately, tubular cells can regenerate and reform the basement
membrane.
- Need to support during regeneration phase.
(c) Rapidly Progressive Glomerulonephritis (RPGN)
Recognition
- Rapid loss of renal function over days to weeks
- Urine contains blood and protein
- Normal or large unobstructed kidneys on ultrasound
- Possible evidence of systemic illness or of disease affecting other
organs (but not always)
Defining the cause
- Blood tests: antineutrophil cytoplasmatic antibodies (ANCA),
antinuclear antibodies (ANA), anti-GBM antibodies, complement
immunoglobulins
- Renal biopsy
Common causes
- Systemic vasculitis (focal necrotising golmerulonephritis)
- SLE
- Goodpasture's (anti-GBM) disease
- Aggressive phase of other inflammatory nephritis e.g. IgA
nephropathy, post-infectious (post-streptococcal)
glomerulonephritis
Management
- Immunosuppressive treatment, e.g. cyclophosphamide and
prednisolone for most causes.
- Supportive treatment, e.g. dialysis when indicated
Clinical Features
I. Pre-renal
- hypotension and signs of poor peripheral perfusion.
- postural hypotension ≥ 20/10mmHg.
- metabolic acidosis, Hyperkalaemia.
II. Intrinsic renal
- Oliguria ( Urine output < 500ml/day)
- ↑ Urea, Creatinine (sometimes rate of rise is
>5mmol/day)
- ↑ K+, ↓ Na+, ↓ Ca++
- Metabolic acidosis
- Signs and symptoms of uraemia (anorexia, nausea,
vomiting, apathy, muscle twitching, hiccoughs, fits,
coma)
- tachypnoea (metabolic acidosis), pulmonary oedema
- Anaemia, bleeding tendency, prone to infection
Investigations
The following investigation should do
- urea & electrolyte, creatinine, CP, CRP and glucose
- Urine stick test, microscopy, biochemistry and
culture & sensitivity
- Arterial blood gases and pH
- Chest X-ray, USG ( abdomen)
- ECG
- Culture and sensitivity of appropriate fluids in case
of sepsis.
continuation from
investigation
Prerenal azotemia Intrinsic ARF
FENa < 1% > 1%
UNa < 10 > 20
Uosm > 500 < 250
BUN/ Cr > 20 < 10- 15
Management
I. Emergency resuscitation
II. Determination of the cause of ARF and specific
treatment of the underlying cause.
III. General management of established ARF
IV. Recovery state (diuretics phase)
I. Emergency resuscitation
(a) Especially K+
> 6mmol/l with ECG changes.
1. IV Ca gluconate 10ml over 5 mins, repeated every 2-3 minutes till
the ECG changes resolved. ( ideal is Ca cholride, Ca contents of CaCl2 is
3-4 times higher than CaCO3 )
2. IV 1.26% NaHCO3 50cc over 5 mins, repeated every 6 hrs.
3. IV soluble insulin 10 units with 50 ml of 50% dextrose over 5
mins, repeated every 6 hrs.
4. Nebulised 15- 20 ml of salbutamol, repeated every 6 hrs.
5. IV Normal saline with IV Frusemide.
(b) Restore the circulatory volume by transfusion with appropriate
fluids. (Monitored by CVP pressure)
(c) Dialysis when there is pulmonary oedema.
II. Determination of the cause of ARF and
specific treatment of the underlying
cause.
(a) Investigation to find out the cause. e.g. USG
(abdomen)
(b) Specific treatment of the underlying cause.
e.g. obstruction should be relieved urgently
Corticosteriod and immunosuppressive drugs in
RPGN.
III. General management of established ARF
Aims. (a) To control fluid and electrolyte balance.
(b) To maintain nutrition.
(c) To control of biochemical abnormality.
(d) To protect the patient from infection.
(e) To consider for RRT (Renal Replacement Therapy)
(a) / (c)
- Daily fluid intake - Urine output + 500 ml.
- Restrict the Na+, K+ intake
- Replace additional fluid and electrolyte
- Daily body weight.
(b)
- Restrict protein intake to 40 g/day (without dialysis) vs 70 g/day
(with dialysis)
- Increase Calorie intake in the form of fat and CHO to suppress
endogenous protein catabolism.
(d) To protect the patient from infection
(e) RRT
- HD (haemodialysis)
- PD (peritoneal dialysis)
- HF (haemofiltration)
- CRRT (continuous renal replacement
therapy) (UF 45ml/ kg/ hr)
IV. Recovery state (diuretics phase)
In case of ATN and obstruction, develop a diuretic phase when
ARF recover.
Need - Appropriate fluid replacement.
- Suppliments of NaCl , NaHCO3, KCl, Ca, PO4, Mg.
Special situation
(A) ARF with sepsis
Cause high mortality of 50-70%
- DIC - recombinent human activated protein ( Drotrecogin alfa)
- PRP,FFP,Cryoprecipitate
- Stress hormone deficiency - IV hydrocortisone 50 mg 6 hrly
- oral fludrocortisone 50 mg/day
for 7 days
- Tight glycemic control with insulin aim the blood glucose level
between 80 - 110mg/ dl.
- IV antibiotics as soon as blood culture was taken.
- Volume replacement in 1st 6 hours of sepsis
(i) crystalloid or colloid
(ii) red cell transfusion to keep Hct to ≥ 30%
(iii) Arginine vasopressin to keep mean arterial pressure > 6.5 mmHg.
If above measures are failed, add dobutamine.
Prognosis
- Mortality is low in uncomplicated ARF even need RRT.
- 50 - 70% in ARF due to serious infection and multiorgan failure.
Poor prognostic features include
- Age > 50 yrs
- Infection (esp. septicaemia)
- Burns ( > 70% surface area)
- Rising urea ( > 16 mmol/ 24hr)
- Oliguric for > 2 wks
- Multi- organ failure ( > 3)
- Jaundice
Acute Renal Failure

More Related Content

What's hot

Anemia in Chronic Kidney DIsease
Anemia in Chronic Kidney DIseaseAnemia in Chronic Kidney DIsease
Anemia in Chronic Kidney DIsease
Vishal Golay
 

What's hot (20)

Tubulointerstitial diseases of Kidney
Tubulointerstitial diseases of KidneyTubulointerstitial diseases of Kidney
Tubulointerstitial diseases of Kidney
 
Renovascular disease
Renovascular diseaseRenovascular disease
Renovascular disease
 
Renal stones
Renal stonesRenal stones
Renal stones
 
Acute kidney injury
Acute kidney injuryAcute kidney injury
Acute kidney injury
 
renal diseases
renal diseasesrenal diseases
renal diseases
 
Acute kidney injury
Acute kidney injuryAcute kidney injury
Acute kidney injury
 
NEPHRITIC SYNDROME / APSGN IN CHILDREN
NEPHRITIC SYNDROME / APSGN IN CHILDREN NEPHRITIC SYNDROME / APSGN IN CHILDREN
NEPHRITIC SYNDROME / APSGN IN CHILDREN
 
Acute kidney injury
Acute kidney injury Acute kidney injury
Acute kidney injury
 
Hepatorenal
HepatorenalHepatorenal
Hepatorenal
 
Obstructive Uropathy of Urology
Obstructive Uropathy of UrologyObstructive Uropathy of Urology
Obstructive Uropathy of Urology
 
Cirrhosis
CirrhosisCirrhosis
Cirrhosis
 
Anemia in Chronic Kidney DIsease
Anemia in Chronic Kidney DIseaseAnemia in Chronic Kidney DIsease
Anemia in Chronic Kidney DIsease
 
Anemia in ckd
Anemia in ckdAnemia in ckd
Anemia in ckd
 
Chronic pyelonephritis
Chronic pyelonephritisChronic pyelonephritis
Chronic pyelonephritis
 
Renal calculi ppt
Renal calculi pptRenal calculi ppt
Renal calculi ppt
 
Nephrotic syndrome
Nephrotic syndromeNephrotic syndrome
Nephrotic syndrome
 
Renovascular disorders
Renovascular disordersRenovascular disorders
Renovascular disorders
 
Lupus nephritis
Lupus nephritisLupus nephritis
Lupus nephritis
 
liver Cirrhosis
liver Cirrhosis liver Cirrhosis
liver Cirrhosis
 
Acute kidney injury
Acute kidney injury Acute kidney injury
Acute kidney injury
 

Similar to Acute Renal Failure

Acute renal failure
Acute renal failureAcute renal failure
Acute renal failure
Muath Matar
 
medicine.Kidney 5.(dr.alaa)
medicine.Kidney 5.(dr.alaa)medicine.Kidney 5.(dr.alaa)
medicine.Kidney 5.(dr.alaa)
student
 
Sudden onset shortness of breath in patient with chronic renal failure
Sudden onset shortness of breath in patient with chronic renal failureSudden onset shortness of breath in patient with chronic renal failure
Sudden onset shortness of breath in patient with chronic renal failure
AR Muhamad Na'im
 
13 Evaluation And Management Of Acute Renal Failure
13 Evaluation And Management Of Acute Renal Failure13 Evaluation And Management Of Acute Renal Failure
13 Evaluation And Management Of Acute Renal Failure
Dang Thanh Tuan
 

Similar to Acute Renal Failure (20)

Medicine 5th year, 1st lecture (Dr. Kawa Husain)
Medicine 5th year, 1st lecture (Dr. Kawa Husain)Medicine 5th year, 1st lecture (Dr. Kawa Husain)
Medicine 5th year, 1st lecture (Dr. Kawa Husain)
 
Acute kidney injury in children
Acute kidney injury in childrenAcute kidney injury in children
Acute kidney injury in children
 
Acute kidney injury
Acute kidney injuryAcute kidney injury
Acute kidney injury
 
Acute renal failure
Acute renal failureAcute renal failure
Acute renal failure
 
medicine.Kidney 5.(dr.alaa)
medicine.Kidney 5.(dr.alaa)medicine.Kidney 5.(dr.alaa)
medicine.Kidney 5.(dr.alaa)
 
Sudden onset shortness of breath in patient with chronic renal failure
Sudden onset shortness of breath in patient with chronic renal failureSudden onset shortness of breath in patient with chronic renal failure
Sudden onset shortness of breath in patient with chronic renal failure
 
Acute kidney Injury
Acute kidney InjuryAcute kidney Injury
Acute kidney Injury
 
acute renal failure in icu
 acute renal failure  in icu acute renal failure  in icu
acute renal failure in icu
 
Aki
AkiAki
Aki
 
Renal Failure in Burn
Renal Failure in BurnRenal Failure in Burn
Renal Failure in Burn
 
13 Evaluation And Management Of Acute Renal Failure
13 Evaluation And Management Of Acute Renal Failure13 Evaluation And Management Of Acute Renal Failure
13 Evaluation And Management Of Acute Renal Failure
 
ACUTE KIDNEY INJURY AND MANAGEMENT
ACUTE KIDNEY INJURY AND MANAGEMENTACUTE KIDNEY INJURY AND MANAGEMENT
ACUTE KIDNEY INJURY AND MANAGEMENT
 
Acute Renal failure
Acute Renal failureAcute Renal failure
Acute Renal failure
 
ARF final.ppt
ARF final.pptARF final.ppt
ARF final.ppt
 
Acute renal failure
Acute renal failure Acute renal failure
Acute renal failure
 
RENAL EMERGENCIES.pptx
RENAL EMERGENCIES.pptxRENAL EMERGENCIES.pptx
RENAL EMERGENCIES.pptx
 
Group 3
Group 3Group 3
Group 3
 
Group 3
Group 3Group 3
Group 3
 
Acute kidney injury (aki)
Acute kidney injury (aki)Acute kidney injury (aki)
Acute kidney injury (aki)
 
Acute kidney Injury today presenting dr. mohamed last 111111 (1).pptx
Acute kidney Injury today presenting dr. mohamed last 111111 (1).pptxAcute kidney Injury today presenting dr. mohamed last 111111 (1).pptx
Acute kidney Injury today presenting dr. mohamed last 111111 (1).pptx
 

More from Cing Sian Dal

More from Cing Sian Dal (20)

Luting agents and cementation
Luting agents and cementation Luting agents and cementation
Luting agents and cementation
 
Instruments used in oral and maxillofacial surgery
Instruments used in oral and maxillofacial surgeryInstruments used in oral and maxillofacial surgery
Instruments used in oral and maxillofacial surgery
 
Final BDS Ortho Photo Slide Test (2018)
Final BDS Ortho Photo Slide Test (2018)Final BDS Ortho Photo Slide Test (2018)
Final BDS Ortho Photo Slide Test (2018)
 
Posterior Crossbite
Posterior CrossbitePosterior Crossbite
Posterior Crossbite
 
Instruments used in oral and maxillofacial surgery
Instruments used in oral and maxillofacial surgeryInstruments used in oral and maxillofacial surgery
Instruments used in oral and maxillofacial surgery
 
Before delivering finished dentures
Before delivering finished denturesBefore delivering finished dentures
Before delivering finished dentures
 
Treatment of crowding in permanent dentition
Treatment of crowding in permanent dentitionTreatment of crowding in permanent dentition
Treatment of crowding in permanent dentition
 
Temporomandibular joint
Temporomandibular jointTemporomandibular joint
Temporomandibular joint
 
Class I Malocclusions
Class I MalocclusionsClass I Malocclusions
Class I Malocclusions
 
Maxillary median diastema
Maxillary median diastemaMaxillary median diastema
Maxillary median diastema
 
Retention in orthodontics
Retention in orthodonticsRetention in orthodontics
Retention in orthodontics
 
Class III Malocclusion
Class III MalocclusionClass III Malocclusion
Class III Malocclusion
 
Overdenture
OverdentureOverdenture
Overdenture
 
Pontic design
Pontic designPontic design
Pontic design
 
Instruction to the patient after denture delivery
Instruction to the patient after denture deliveryInstruction to the patient after denture delivery
Instruction to the patient after denture delivery
 
Class II malocclusion
Class II malocclusionClass II malocclusion
Class II malocclusion
 
Immediate denture
Immediate denture Immediate denture
Immediate denture
 
Pontics and Retainers
Pontics and RetainersPontics and Retainers
Pontics and Retainers
 
Acrylic partial denture
Acrylic partial dentureAcrylic partial denture
Acrylic partial denture
 
Halitosis
HalitosisHalitosis
Halitosis
 

Recently uploaded

Mastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial FreedomMastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial Freedom
FatimaMary4
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
DR SETH JOTHAM
 

Recently uploaded (20)

Mastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial FreedomMastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial Freedom
 
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
 
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptxANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
 
Compare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from homeCompare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from home
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
 
Fundamental of Radiobiology -SABBU.pptx
Fundamental of Radiobiology  -SABBU.pptxFundamental of Radiobiology  -SABBU.pptx
Fundamental of Radiobiology -SABBU.pptx
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
 
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptxFinal CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Anuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentAnuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatment
 
Blue Printing in medical education by Dr.Mumtaz Ali.pptx
Blue Printing in medical education by Dr.Mumtaz Ali.pptxBlue Printing in medical education by Dr.Mumtaz Ali.pptx
Blue Printing in medical education by Dr.Mumtaz Ali.pptx
 
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
 

Acute Renal Failure

  • 1. Acute Kidney Injury Dr Thuzar Win Lecturer Department of Medicine University of Medicine (2) Yangon
  • 2. Definition Refers to a sudden and usually reversible loss of renal function, which develops over a period of days or weeks.
  • 3. Working Definition  Serum creatinine rises by 26 µmol/L within 48 hours; or  Serum creatinine rises by 1.5-fold from the baseline value, either known or thought to have occurred within one week; or  Urine output is less than 0.5 mL/kg/hour for more than six consecutive hours.
  • 4. Causes Are divided into I. Pre-renal (usually reversible and commonest) -55-60% II. Intrinsic renal -35-40% III. Post-renal - < 5 %
  • 5. I. Pre-renal causes (a) systemic i – Intravascular volume deplesion  haemorrhage,  GI loss,  renal loss by excessive diuresis,  increased insensible loss  third space losses (pancretitis, crush Syndrome)
  • 6. continuation from pre-renal cause-1 • ii - Decreased cardiac output a) cardiac failure, b) systemic vasodilatation c) drug induced d) sepsis, liver failure, anaphylaxis
  • 7. continuation from pre-renal cause-2 (b) local i - renal artery occlusion or stenosis ii - disease affecting renal arterioles iii - renal vasoconstrition(norepinephrine, ergotamine,liver disease, sepsis, hypercalcemia). iv - pharmacological agents that acutely impair the autoregulation and GFR( ACEI, NSAIDs )
  • 8. II. Intrinsic renal disease (a) Acute tubular necrosis 85% Toxic / Septic renal failure (b) Glomerular disease - Primary - Component of systemic disease 5% (vasculitis, accelerated hypertension, DIC) (c) Interstitial disease 10% (acute allergic interstitial nephritis due to drugs)
  • 9. III. Post-renal (a) Stones (b) Inflammation if it is bilateral (c) Tumor.
  • 10.
  • 11. Pathogenesis I. Pre-renal Kidney can regulate its own blood flow and GFR over a wide range of perfusion pressures Compensatory mechanism (a) VD of afferent arterioles (b) VC of efferent arterioles - mechanical - neurohumoral -PGs which is inhibited by NSAIDs. -Renin -Ag II which is inhibited by ACEI
  • 12. When compensatory mechanism fails, intact renal tubules become hyperfunctional and lead to increase absorption of Na and H2O. Physical factors Angiotensin, Aldosterone, Vasopressin low urine volume.(Hyperosmolar) low urinary Na.
  • 13. II. Intrinsic renal (a) Acute tubular necrosis (ATN) (b) Sepsis (c) Rapidly progressive glomerulonephritis (RPGN) (a) Acute Tubular Necrosis (ATN) (i) ischaemic ATN (ii) nephrotoxic ATN
  • 14. (a) (i) ischaemic ATN - follows after shock and renal blood flow remains 20% of normal - reduced O2 delivery to tubular cells. - peroxidation of cell membrane lipids, influx of Ca and cell swelling. - mitochondrial function impaired - anaerobic glycolysis and intracellular acidosis - lysosomal disruption, denaturing of protein and DNA tubular cell death
  • 15. (a) (ii) Nephrotoxic ATN - Direct toxicity to tubular cells - Production of reactive O2 species and peroxidation of membrane lipids - interfere with cellular respiration and inhibition of cell protein synthesis tubular cell death
  • 16. Tubular cell death - loss of adhesion between tubular cell and basement membrane - shedding of cell -focal break in tubular into tubular lumen basement membrane tubular obstruction - tubular content leak into interstitial tissue interstitial oedema
  • 17. (b) Sepsis (many mechanisms causing ATN) - Generated arterial vasodilatation. - Activation of sympathetic nervous system. - Activation of RAA axis (vascular resistance) - Non-osmotic release of vasopressin. - Increase in cardiac output. - Development of DIC. - Deficiency of stress hormones, cortisol. - Metabolic changes like hyperglycemia. - Fortunately, tubular cells can regenerate and reform the basement membrane. - Need to support during regeneration phase.
  • 18. (c) Rapidly Progressive Glomerulonephritis (RPGN) Recognition - Rapid loss of renal function over days to weeks - Urine contains blood and protein - Normal or large unobstructed kidneys on ultrasound - Possible evidence of systemic illness or of disease affecting other organs (but not always) Defining the cause - Blood tests: antineutrophil cytoplasmatic antibodies (ANCA), antinuclear antibodies (ANA), anti-GBM antibodies, complement immunoglobulins - Renal biopsy
  • 19. Common causes - Systemic vasculitis (focal necrotising golmerulonephritis) - SLE - Goodpasture's (anti-GBM) disease - Aggressive phase of other inflammatory nephritis e.g. IgA nephropathy, post-infectious (post-streptococcal) glomerulonephritis Management - Immunosuppressive treatment, e.g. cyclophosphamide and prednisolone for most causes. - Supportive treatment, e.g. dialysis when indicated
  • 20. Clinical Features I. Pre-renal - hypotension and signs of poor peripheral perfusion. - postural hypotension ≥ 20/10mmHg. - metabolic acidosis, Hyperkalaemia.
  • 21. II. Intrinsic renal - Oliguria ( Urine output < 500ml/day) - ↑ Urea, Creatinine (sometimes rate of rise is >5mmol/day) - ↑ K+, ↓ Na+, ↓ Ca++ - Metabolic acidosis - Signs and symptoms of uraemia (anorexia, nausea, vomiting, apathy, muscle twitching, hiccoughs, fits, coma) - tachypnoea (metabolic acidosis), pulmonary oedema - Anaemia, bleeding tendency, prone to infection
  • 22. Investigations The following investigation should do - urea & electrolyte, creatinine, CP, CRP and glucose - Urine stick test, microscopy, biochemistry and culture & sensitivity - Arterial blood gases and pH - Chest X-ray, USG ( abdomen) - ECG - Culture and sensitivity of appropriate fluids in case of sepsis.
  • 23. continuation from investigation Prerenal azotemia Intrinsic ARF FENa < 1% > 1% UNa < 10 > 20 Uosm > 500 < 250 BUN/ Cr > 20 < 10- 15
  • 24. Management I. Emergency resuscitation II. Determination of the cause of ARF and specific treatment of the underlying cause. III. General management of established ARF IV. Recovery state (diuretics phase)
  • 25. I. Emergency resuscitation (a) Especially K+ > 6mmol/l with ECG changes. 1. IV Ca gluconate 10ml over 5 mins, repeated every 2-3 minutes till the ECG changes resolved. ( ideal is Ca cholride, Ca contents of CaCl2 is 3-4 times higher than CaCO3 ) 2. IV 1.26% NaHCO3 50cc over 5 mins, repeated every 6 hrs. 3. IV soluble insulin 10 units with 50 ml of 50% dextrose over 5 mins, repeated every 6 hrs. 4. Nebulised 15- 20 ml of salbutamol, repeated every 6 hrs. 5. IV Normal saline with IV Frusemide.
  • 26. (b) Restore the circulatory volume by transfusion with appropriate fluids. (Monitored by CVP pressure) (c) Dialysis when there is pulmonary oedema.
  • 27. II. Determination of the cause of ARF and specific treatment of the underlying cause. (a) Investigation to find out the cause. e.g. USG (abdomen) (b) Specific treatment of the underlying cause. e.g. obstruction should be relieved urgently Corticosteriod and immunosuppressive drugs in RPGN.
  • 28. III. General management of established ARF Aims. (a) To control fluid and electrolyte balance. (b) To maintain nutrition. (c) To control of biochemical abnormality. (d) To protect the patient from infection. (e) To consider for RRT (Renal Replacement Therapy)
  • 29. (a) / (c) - Daily fluid intake - Urine output + 500 ml. - Restrict the Na+, K+ intake - Replace additional fluid and electrolyte - Daily body weight. (b) - Restrict protein intake to 40 g/day (without dialysis) vs 70 g/day (with dialysis) - Increase Calorie intake in the form of fat and CHO to suppress endogenous protein catabolism. (d) To protect the patient from infection
  • 30. (e) RRT - HD (haemodialysis) - PD (peritoneal dialysis) - HF (haemofiltration) - CRRT (continuous renal replacement therapy) (UF 45ml/ kg/ hr)
  • 31. IV. Recovery state (diuretics phase) In case of ATN and obstruction, develop a diuretic phase when ARF recover. Need - Appropriate fluid replacement. - Suppliments of NaCl , NaHCO3, KCl, Ca, PO4, Mg. Special situation (A) ARF with sepsis Cause high mortality of 50-70% - DIC - recombinent human activated protein ( Drotrecogin alfa) - PRP,FFP,Cryoprecipitate
  • 32. - Stress hormone deficiency - IV hydrocortisone 50 mg 6 hrly - oral fludrocortisone 50 mg/day for 7 days - Tight glycemic control with insulin aim the blood glucose level between 80 - 110mg/ dl. - IV antibiotics as soon as blood culture was taken.
  • 33. - Volume replacement in 1st 6 hours of sepsis (i) crystalloid or colloid (ii) red cell transfusion to keep Hct to ≥ 30% (iii) Arginine vasopressin to keep mean arterial pressure > 6.5 mmHg. If above measures are failed, add dobutamine.
  • 34. Prognosis - Mortality is low in uncomplicated ARF even need RRT. - 50 - 70% in ARF due to serious infection and multiorgan failure. Poor prognostic features include - Age > 50 yrs - Infection (esp. septicaemia) - Burns ( > 70% surface area) - Rising urea ( > 16 mmol/ 24hr) - Oliguric for > 2 wks - Multi- organ failure ( > 3) - Jaundice